Form 4: VIAVI Director Sells 25,000 Shares in Planned Transaction

VIAVI Solutions Director Donald A. Colvin sold 25,000 shares of common stock at a weighted average price of $29.23 per share under a Rule 10b5-1 plan.

Summary

• Donald A. Colvin, a Director of VIAVI SOLUTIONS INC. (VIAV), reported a sale of common stock.
• The transaction involved the disposition of 25,000 shares of Common Stock.
• The sale occurred on February 26, 2026, at a weighted average price of $29.23 per share.
• The transaction was executed in multiple trades with prices ranging from $29.20 to $29.29.
• Following this transaction, Donald A. Colvin beneficially owns 147,053 shares of Common Stock.
• The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly negative event. The sale itself is a factual reduction in insider ownership, but the pre-planned nature via a 10b5-1 plan mitigates immediate concerns about a lack of confidence.

Positives

• The transaction was conducted under a Rule 10b5-1 plan, indicating it was pre-scheduled and not based on new, non-public information, which can mitigate concerns about insider selling.

Negatives

• A director selling 25,000 shares, even if planned, reduces their direct equity stake in the company, which can sometimes be perceived negatively by the market.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are closely watched by investors for signals regarding management's confidence in the company's future. While a Rule 10b5-1 plan indicates a pre-arranged sale, it still represents a reduction in insider ownership, which can be interpreted differently across the industry depending on the size of the sale relative to total holdings and the individual's compensation structure.

Stakeholder Impact

• Shareholders may interpret the director's sale as a signal, potentially influencing their perception of the stock's value or future prospects, despite the 10b5-1 plan.

Key Dates

Recommendation

A single Form 4 filing detailing a pre-planned insider sale, while noteworthy, typically does not warrant a strong buy or sell recommendation on its own. Investors should 'hold' and monitor for broader patterns of insider activity, company performance, and market conditions before making significant investment decisions. The 10b5-1 plan suggests the sale is for personal financial planning rather than a reaction to new company-specific information.

Keywords

VIAVI Solutions, VIAV, Insider Trading, Form 4, Director Sale, Stock Transaction, Rule 10b5-1